Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Shuttle Pharmaceuticals Holdings, Inc./ 10-K

Annual Report · 10-K

Shuttle Pharmaceuticals Holdings, Inc.

SHPHNASDAQEQUITYCurrent

Annual Report

Filed Mar 31, 2026Accepted Mar 31, 2026, 4:05 PM EDTCIK 1757499Accession 0001493152-26-014131
View company →Permanent SEC source ↗
Share

Company context

Shuttle Pharma is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. Our goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (“radiation therapy” or “RT”) is one of the most effective modalities for treating cancers. We are developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. We believe that our product candidates will enable us to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.

Current securities

SHPHNASDAQ · EQUITY · Current

Recent company filings

  1. Changes in Registrant's Certifying AccountantOct 22, 2026
  2. 10-Q filingSep 24, 2026
  3. Financial Statements and ExhibitsSep 24, 2026
  4. Unregistered Sales of Equity SecuritiesSep 16, 2026
  5. Submission of Matters to a Vote of Security HoldersSep 11, 2026

Registered securities in this filing

Shuttle Pharmaceuticals Holdings, Inc. · 10-K · Filed 2026-03-31

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock

Symbol
SHPH
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: From2025-01-01to2025-12-31

Dimensions: Not supplied

Accession 000149315226014131 · 1 registered-security cover member

Read the exact SEC filing ↗

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.